Medical News

RSS

Viewpoints: McKinsey report contentiousness; Medicare facts vs. beliefs; insurers' HSA 'strategy'

The White House routinely tries to intimidate its health-care critics, but the campaign against McKinsey & Co. is something else. The management consultants attempted to find out how U.S. business will respond to the government restructuring of 17.3% of the economy, Democrats don't like the results, and so McKinsey must pay with its reputation.

24 Jun 2011

AIS introduces Spectral karyotyping

AIS introduces Spectral karyotyping (SKY®) equipment, designed and manufactured by ASI, a leading developer of comprehensive solutions for pathology and cytogenetics. Spectral karyotyping (SKY®) is ASI’s novel addition to the cytogenetic tool kit. It is based on a unique electro-optical hardware that enables measuring the spectral image of a metaphase, previously stained, such that each chromosome class has a different color (created typically from different combinations of 5 or more basic dyes).

23 Jun 2011

WA alcohol regulations sparks debate

According to the liquor industry tightening alcohol regulations by toughening availability of alcohol in Western Australia will only serve to push addicts and binge drinkers onto other drugs.

23 Jun 2011

‘City slickers’ at increased brain stress: Study

German and Canadian neuroscientists have shown that living in a city or even being raised in one is associated with differences in the way the brain handles stress. They write in Nature that this is the first time researchers have used functional magnetic resonance imaging (fMRI) to identify specific brain regions that are affected by urban life.

23 Jun 2011

U.S. Supreme Court ruling on generic drugs

According to the new ruling from the U.S. Supreme Court, people harmed by generic drugs may find it harder to get restitution. The court ruled on Thursday that generic drug makers cannot be sued for failing to warn consumers of their products' side effects if they copy the exact warnings on the drugs' brand-name equivalents.

23 Jun 2011

Elderly alcohol and drug abuse support

A report has advised that the British government alter the recommended amount of alcohol older people should consume. The government should cut the recommended drinking limits for older people, according to doctors, in a move likely to affect many looking to find a care home.

23 Jun 2011

Some drug mixtures may be fatal for elderly: study

British scientists warn that well known brands of hay fever tablets, painkillers and sleeping pills pose a previously unknown threat to elderly people’s health when taken together. Many are available over the counter at pharmacies as well as being prescribed by GPs, nurses and chemists they said.

23 Jun 2011

Payroll agitation for Queensland health workers

The health workers’ unions of Queensland have rallied at Chermside to highlight the unresolved pay problems, and demand more recognition for the extra work and expertise involved in running the new payroll system.

23 Jun 2011

RACGP welcomes Senate Inquiry into mental health funding cuts

The Royal Australian College of General Practitioners (RACGP) has welcomed the move yesterday to hold a Senate Inquiry into the Federal Government’s decision to cut the Medicare patient rebates for GP mental health services in the 2011‐2012 Federal Budget. The Senate Inquiry comes after strong and consistent lobbying on the issue by the RACGP and our colleagues within United General Practice Australia (UGPA).

23 Jun 2011

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF’s KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology’s research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).

23 Jun 2011

Centrix and CutisPharma enter promotional agreement for vaginal suppository compounding kits

Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company.

23 Jun 2011

Reductions in obesity-related medical costs offset cost of gastric banding surgery within 2.25 years

Allergan, Inc. today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan's LAP-BAND Adjustable Gastric Banding System, was offset by reductions in obesity-related medical costs within 2.25 years for surgery eligible patients with diabetes, and within four years of the procedure for all surgery eligible patients.

23 Jun 2011

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.

23 Jun 2011

Majority of cancers are due to epigenetic influences

Dr. Ajay Goel, Ph.D., Director of Epigenetics and Cancer Prevention at the Gastrointestinal Research Center at Baylor University Medical Center in Dallas, TX, has announced plans for a series of upcoming studies to continue to unlock the mechanisms by which curcumin prevents cancer via its influence on epigenetic activity.

23 Jun 2011

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

Varian Medical Systems today announced that the company's TrueBeam system for image-guided radiotherapy and radiosurgery has received a 2011 R&D 100 Award from R&D Magazine. This annual award salutes the 100 most technologically significant products of the prior year, spanning many categories, from biomedical products to consumer items.

23 Jun 2011

Health Canada approves PURE Hard Surface disinfectant

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Health Canada has approved PURE™ Hard Surface disinfectant for use in food premises, hospitals and health care facilities, domestic locations and institutional and industrial premises.

23 Jun 2011

Cyanotech fourth quarter revenues increase to $5,218,000

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for the fourth quarter and fiscal year 2011, ended March 31, 2011.

23 Jun 2011

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).

23 Jun 2011

MU and Coulter Foundation enter $5 million grant agreement for biomedical research

University of Missouri officials announced today a $5 million grant agreement with the Wallace H. Coulter Foundation, through the Foundation's Translational Partnership Award Program. The goal of the partnership is to develop technologies that will save, extend and improve patient lives and suffering from any disease or condition in any country around the world.

23 Jun 2011

Spinal manipulative therapy provides minor but significant benefits for patients with chronic low back pain

Spinal manipulative therapy (SMT) has significant but very small benefits for patients with chronic low back pain, according to a special review article in the June 1 issue of Spine.

23 Jun 2011

Medical News

Viewpoints: McKinsey report contentiousness; Medicare facts vs. beliefs; insurers' HSA 'strategy'

AIS introduces Spectral karyotyping

WA alcohol regulations sparks debate

‘City slickers’ at increased brain stress: Study

U.S. Supreme Court ruling on generic drugs

Elderly alcohol and drug abuse support

Some drug mixtures may be fatal for elderly: study

Payroll agitation for Queensland health workers

RACGP welcomes Senate Inquiry into mental health funding cuts

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Centrix and CutisPharma enter promotional agreement for vaginal suppository compounding kits

Reductions in obesity-related medical costs offset cost of gastric banding surgery within 2.25 years

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Majority of cancers are due to epigenetic influences

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

Health Canada approves PURE Hard Surface disinfectant

Cyanotech fourth quarter revenues increase to $5,218,000

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

MU and Coulter Foundation enter $5 million grant agreement for biomedical research

Spinal manipulative therapy provides minor but significant benefits for patients with chronic low back pain

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News